• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

Trump admits he’s taking the same anti-malaria drug that the FDA warns against

By
Justin Sink
Justin Sink
,
Jordan Fabian
Jordan Fabian
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Justin Sink
Justin Sink
,
Jordan Fabian
Jordan Fabian
and
Bloomberg
Bloomberg
Down Arrow Button Icon
May 19, 2020, 5:37 AM ET

President Donald Trump said he is taking hydroxychloroquine, the anti-malaria drug that he’s promoted as a treatment to combat coronavirus infection, despite government warnings that it can cause serious side effects.

Trump said Monday at the White House that he’s been taking the drug for about a week and half. Vice President Mike Pence’s press secretary, Katie Miller, tested positive for coronavirus on May 8. Trump was not seen in Pence’s company following the diagnosis until Monday, when the vice president joined him for a meeting with restaurateurs.

Trump is a self-admitted germophobe, telling reporters he was wary of shaking hands even before the coronavirus pandemic, and theatrically distancing himself from former patients during press events.

At the same time, he has avoided other steps recommended by public health experts to slow the spread of the virus, such as wearing a mask. The Centers for Disease Control and Prevention says that wearing a mask when social distancing is not possible could prevent people who have the virus but don’t know it from spreading it to others.

The president has dismissed suggestions that he put on a mask, saying he is tested frequently. He said Monday he receives a test “every couple of days” and added he has “shown always negative.”

There is scant evidence that hyroxychloroquine is effective against the coronavirus. The Food and Drug Administration on April 24 cautioned against the use of hydroxychloroquine or chloroquine for Covid-19, the illness caused by the coronavirus, outside of a hospital setting or clinical trial, citing a risk of heart rhythm problems.

“I want the people of this nation to feel good,” Trump said at the meeting, where he disclosed to reporters that he’s taking the drug. He also said he had taken azithromycin, an antibiotic commonly known as a z-pak, and that he is taking a zinc supplement.

“There is a very good chance this has an impact, especially early on,” he said. “I’m telling you, so far I seem O.K.”

Pence didn’t answer when reporters asked whether he, too, was taking the drug. The White House didn’t immediately respond to a question about whether Miller’s diagnosis prompted Trump to begin taking it.

On Monday night, the White House released a memorandum from Sean Conley, the physician to the president and a Navy commander. Conley said in the memo that after discussions with Trump “for and against the use of hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risks.”

The memo, however, did not say whether the doctor had actually prescribed the drug, or if Trump is taking it. Conley did confirm that the president “receives regular Covid-19 testing, all negative to date.”

“I get a lot of positive calls about it”

The National Institutes of Health’s Covid-19 Treatment Guidelines say the malaria drug alone should be avoided at high doses or with azithromycin, outside of clinical trials, because of the same concerns. One of Trump’s top medical advisers, Anthony Fauci, the director of the National Institute of Allergy and Infectious Disease, has publicly discouraged use of the drug against the coronavirus.

Read More: Trump-Touted Malaria Drug Fails in Covid-19 Study

“Here’s my evidence: I get a lot of positive calls about it,” Trump said. He added that he had not started taking the drug at the recommendation of his doctor, but had instead asked the White House physician whether he could take it and was told he could.

Trump first began touting the drug in mid-March, creating a rush for supplies of the pills among hospitals, doctors and people who wanted to use it as a preventive. The surge created shortages for lupus and rheumatoid arthritis patients, who also use the medicine. In April, azithromycin also went into shortage, according to the FDA.

During the week of March 20, hydroxychloroquine prescriptions jumped to 298,660, more than double a week earlier, according to data compiled by Bloomberg Intelligence. Prescriptions have since plummeted back to nearly normal levels.

When used by healthy patients on its own, hydroxychloroquine has a relatively well-established profile and is considered low-risk.

In several trials of hospitalized, severely ill patients with Covid-19, it has been shown to raise heart risks and rates of death when combined with azithromycin. The medicine is known to interfere with the heart’s electrical signals in extremely rare cases, and can cause sudden death.

Alarm on Fox

The president’s announcement was met by alarm on Fox News, where anchor Neil Cavuto pointed to a Department of Veterans Affairs study showing it was linked to higher rates of death in hospitalized Covid-19 patients with pre-existing conditions and other studies showing it was ineffective.

“If you are in a risky population here, and you are taking this as a preventative treatment to ward off the virus, or in a worst-case scenario you are dealing with the virus, and you are in this vulnerable population, it will kill you,” Cavuto said on-air. “I cannot stress enough: this will kill you.”

Some of the network’s opinion hosts, in particular Laura Ingraham, have promoted use of the drug against the coronavirus. Ingraham has met with Trump at the White House to advocate for the malaria drug, according to the Washington Post.

Trump, who will be 74 next month, suffers from pre-existing conditions including high cholesterol and obesity, according to reports from his medical exams as president.

About the Authors
By Justin Sink
See full bioRight Arrow Button Icon
By Jordan Fabian
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon

Latest in Health

HealthHealth
These toxic wild mushrooms have caused a deadly outbreak of poisoning in California
By The Associated PressDecember 7, 2025
15 hours ago
Schumer
Politicsnational debt
‘This is a bad idea made worse’: Senate Dems’ plan to fix Obamacare premiums adds nearly $300 billion to deficit, CRFB says
By Nick LichtenbergDecember 5, 2025
2 days ago
Best vegan meal delivery
Healthmeal delivery
Best Vegan Meal Delivery Services of 2025: Tasted and Reviewed
By Christina SnyderDecember 5, 2025
2 days ago
Retailmeal delivery
Best Prepared Meal Delivery Services of 2025: RD Approved
By Christina SnyderDecember 5, 2025
2 days ago
Gen Z
EconomyGen Z
America, meet your alienated youth: ‘Gold standard’ Harvard survey reveals Gen Z’s anxiety and distrust, defined by economic insecurity
By Nick LichtenbergDecember 4, 2025
3 days ago
Jensen Huang
SuccessBillionaires
Nvidia CEO Jensen Huang admits he works 7 days a week, including holidays, in a constant ‘state of anxiety’ out of fear of going bankrupt
By Jessica CoacciDecember 4, 2025
4 days ago

Most Popular

placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in a weekend'
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House economic adviser says
By Jason MaDecember 6, 2025
1 day ago
placeholder alt text
Economy
JPMorgan CEO Jamie Dimon says Europe has a 'real problem’
By Katherine Chiglinsky and BloombergDecember 6, 2025
1 day ago
placeholder alt text
Big Tech
Mark Zuckerberg rebranded Facebook for the metaverse. Four years and $70 billion in losses later, he’s moving on
By Eva RoytburgDecember 5, 2025
3 days ago
placeholder alt text
Politics
Supreme Court to reconsider a 90-year-old unanimous ruling that limits presidential power on removing heads of independent agencies
By Mark Sherman and The Associated PressDecember 7, 2025
15 hours ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.